Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome


Autoria(s): Rodrigues, C. E. M.; Vendramini, M. B.; Bueno, C.; Bonfa, E.; de Carvalho, J. F.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

06/11/2013

06/11/2013

2012

Resumo

Objective This study was undertaken to evaluate a possible association of adipocytokines with metabolic syndrome (MetS), inflammation and other cardiovascular risk factors in primary antiphospholipid syndrome (PAPS). Methods Fifty-six PAPS patients and 72 controls were included. Adiponectin, leptin, visfatin, resistin, plasminogen activator inhibitor-1 (PAI-1), lipoprotein (a), glucose, ESR, CRP, uric acid and lipid profiles were measured. The presence of MetS was determined as defined by the International Diabetes Federation (IDF), and insulin resistance was rated using the homeostasis model assessment (HOMA) index. Results Concentrations of leptin were higher [21.5 (12.9-45.7) ng/mL] in PAPS patients than in the controls ([2.1 (6.9-26.8) ng/mL), p=0.001]. In PAPS patients, leptin and PAI-1 levels were positively correlated with BMI (r=0.61 and 0.29), HOMA-IR (r=0.71 and 0.28) and CRP (r=0.32 and 0.36). Adiponectin levels were negatively correlated with BMI (r=-0.28), triglycerides (r=-0.43) and HOMA-IR (r=-0.36) and positively correlated with HDL-c (r=0.37) and anti-beta 2GPI IgG (r=0.31). The presence of MetS in PAPS patients was associated with higher levels of leptin (p=0.002) and PAI-1 (p=0.03) levels and lower levels of adiponectin (p=0.042). Variables that independently influenced the adiponectin concentration were the triglyceride levels (p<0.001), VLDL-c (P=0.002) and anti-beta 2GPI IgG (p=0.042); the leptin levels were BMI (p<0.001), glucose (p=0.046), HOMA-IR (p<0.001) and ESR (p=0.006); and the PAI-1 levels were CRP (p=0.013) and MetS (p=0.048). Conclusion This study provides evidence that adipocytokines may be involved in low-grade inflammation, insulin resistance and MetS in PAPS patients.

Federico Foundation

Federico Foundation

FAPESP [2009/14784-8]

FAPESP

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [300665/2009-1, 301411/2009-3]

Identificador

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, PISA, v. 30, n. 6, pp. 871-878, NOV-DEC, 2012

0392-856X

http://www.producao.usp.br/handle/BDPI/42223

Idioma(s)

eng

Publicador

CLINICAL & EXPER RHEUMATOLOGY

PISA

Relação

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Direitos

restrictedAccess

Copyright CLINICAL & EXPER RHEUMATOLOGY

Palavras-Chave #ADIPOCYTOKINES #INFLAMMATION #INSULIN RESISTANCE #METABOLIC SYNDROME #PRIMARY ANTIPHOSPHOLIPID SYNDROME #SYSTEMIC-LUPUS-ERYTHEMATOSUS #DENSITY LIPOPROTEIN CHOLESTEROL #RHEUMATOID-ARTHRITIS #CORONARY ATHEROSCLEROSIS #RISK-FACTORS #ADIPONECTIN CONCENTRATIONS #CARDIOVASCULAR-DISEASE #CONSENSUS STATEMENT #PLASMA ADIPONECTIN #LEPTIN #RHEUMATOLOGY
Tipo

article

original article

publishedVersion